Axogen (AXGN) Net Income towards Common Stockholders (2010 - 2026)

Axogen (AXGN) recorded quarterly Net Income towards Common Stockholders of -$2.8 million in Q1 2026, up 75.24% quarter-over-quarter from -$11.1 million in Q4 2025, and up 24.21% on a YoY basis from -$2.2 million in Q1 2025.

Axogen (AXGN) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Axogen's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$2.8 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 24.21% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at -$13.5 million (down 82.53% YoY), while the FY2025 annual figure was -$14.4 million, down 38.94% from the prior year.
  • Net Income towards Common Stockholders was -$2.8 million for Q1 2026 at Axogen, up from -$11.1 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $541000.0 in Q4 2024 to a low of -$11.7 million in Q1 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$4.7 million across 5 years, with a median of -$4.7 million in 2023.
  • Biggest YoY gain for Net Income towards Common Stockholders was 124.78% in 2025; the steepest drop was 2158.78% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$5.2 million in 2022, then grew by 9.09% to -$4.7 million in 2023, then jumped by 111.51% to $541000.0 in 2024, then slumped by 2158.78% to -$11.1 million in 2025, then surged by 75.24% to -$2.8 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$2.8 million (Q1 2026), -$11.1 million (Q4 2025), and $474000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Axogen 2.22 Bn 2.12 Bn 46.19 Mn -2.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.76 Mn
Dec 31, 2025 -11.14 Mn
Sep 30, 2025 474,000.00
Jun 30, 2025 -80,000.00
Mar 31, 2025 -3.64 Mn
Dec 31, 2024 541,000.00
Sep 30, 2024 -1.91 Mn
Jun 30, 2024 -2.39 Mn
Mar 31, 2024 -6.59 Mn
Dec 31, 2023 -4.70 Mn
Sep 30, 2023 -4.49 Mn
Jun 30, 2023 -6.82 Mn
Mar 31, 2023 -6.81 Mn
Dec 31, 2022 -5.17 Mn
Sep 30, 2022 -4.73 Mn
Jun 30, 2022 -8.14 Mn
Mar 31, 2022 -11.72 Mn
Dec 31, 2021 -5.27 Mn
Sep 30, 2021 -7.09 Mn
Jun 30, 2021 -7.69 Mn